Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients.

OBJECTIVE Venoarterial extracorporeal membrane oxygenation is an established treatment option in patients with cardiogenic shock. This report reviews our 3-year experience with this support system with respect to early and midterm outcome, as well as predictors of survival. METHODS From January 2003 until November 2006, 45 (0.8%) of 5750 patients undergoing cardiac surgery procedures required the following: temporary extracorporeal membrane oxygenation support coronary artery bypass grafting, n = 20; implantation of a left ventricular assist device, n = 5; heart transplantation, n = 1; heart and lung transplantation, n = 1; coronary artery bypass grafting plus repair of postinfarction ventricular septal defect, n = 3; coronary artery bypass grafting plus mitral valve repair, n = 5; aortic valve replacement, n = 2; coronary artery bypass grafting plus aortic valve replacement, n = 3; and other procedures, n = 5. Extracorporeal membrane oxygenation implantation was performed through the femoral vessels or axillary artery or through the right atrium and ascending aorta. Additional intra-aortic balloon pumps were used in 30 patients. RESULTS Average patient age was 60.1 +/- 13.6 years. There were 35 male patients. Average duration of extracorporeal membrane oxygenation was 6.4 +/- 4.5 days. Twenty-five patients could be successfully weaned from extracorporeal membrane oxygenation. The 30-day mortality was 53% (24/45 patients). The in-hospital mortality was 71% (32/45 patients). Thirteen (29%) patients could be successfully discharged. After a follow-up period of up to 3 years, 10 (22%) patients were still alive. CONCLUSIONS Extracorporeal membrane oxygenation offers sufficient cardiopulmonary support in adults with similar hospital and midterm survival rates to those of other mechanical support systems. Early indication, alternative peripheral cannulation techniques, and reduced anticoagulation to avoid perioperative bleeding could improve our results with increasing experience.

[1]  M. Czerny,et al.  Late vascular complications after extracorporeal membrane oxygenation support. , 2006, The Annals of thoracic surgery.

[2]  Yih-Sharng Chen.  Pediatric in--intensive-care-unit cardiac arrest: New horizon of extracorporeal life support. , 2006, Critical care medicine.

[3]  P. McCarthy,et al.  Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. , 1996, The Annals of thoracic surgery.

[4]  R. Bellomo,et al.  An extracorporeal membrane oxygenation-based approach to cardiogenic shock in an older population. , 2001, The Annals of thoracic surgery.

[5]  L. Golding.  Postcardiotomy mechanical support. , 1991, Seminars in thoracic and cardiovascular surgery.

[6]  J J Osborn,et al.  Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. , 1972, The New England journal of medicine.

[7]  G. Zaloga.  Early enteral nutritional support improves outcome: hypothesis or fact? , 1999, Critical care medicine.

[8]  B. Kiaii,et al.  Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. , 2004, The Annals of thoracic surgery.

[9]  J. Younger,et al.  Extracorporeal life support: the University of Michigan experience. , 2000, JAMA.

[10]  S. Bolling,et al.  Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization. , 1999, Circulation.

[11]  R. Thiagarajan,et al.  Extracorporeal membrane oxygenation for cardiac arrest: when to use it, and what are the outcomes? , 2006, Critical care medicine.

[12]  N. Doll,et al.  Temporary Extracorporeal Membrane Oxygenation in Patients with Refractory Postoperative Cardiogenic Shock—A Single Center Experience , 2003, Journal of cardiac surgery.

[13]  A. Morris.  Extracorporeal support and patient outcome: credible causality remains elusive. , 2006, Critical care medicine.

[14]  N. Smedira,et al.  Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. , 2001, The Journal of thoracic and cardiovascular surgery.